TEVOGEN BIO

tevogen-bio-logo

A clinical stage biotech company developing curative and preventative treatments to positively impact global public health. Tevogen is developing T cell immunotherapies in virology, oncology, and neurology, by utilizing patented precision T cell platform technology. Its current intellectual property portfolio includes several breakthrough cell and gene therapy platforms.

#SimilarOrganizations #People #Financial #Event #Website #More

TEVOGEN BIO

Social Links:

Industry:
Biopharma Biotechnology Health Care Life Science Medical Oncology Pharmaceutical Product Research Therapeutics

Founded:
2020-01-01

Address:
Warren, New Jersey, United States

Country:
United States

Website Url:
http://www.tevogen.com

Total Employee:
11+

Status:
Active

Contact:
1 877 838-6436

Email Addresses:
[email protected]

Total Funding:
58 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Font Awesome Global Site Tag Organization Schema


Similar Organizations

arctic-therapeutics-logo

Arctic Therapeutics

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

csts-health-care-logo

CSTS Health Care

Biotech, Precision Oncology, Platelet Facilitated Drugs (PFDs)

iact-health-logo

IACT Health

IACT Health is a research and development firm that performs clinical trials for oncology, cardiology, pulmonology and endocrinology.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

omnia-biosystems-logo

Omnia Biosystems

Omnia Biosystems is addressing challenging targets in oncology using artificial intelligence.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.


Current Advisors List

kendell-r-sprott_image

Kendell R. Sprott Corporate Advisory Board @ Tevogen Bio
Board_member
2022-01-01

Current Employees Featured

sadiq-khan_image

Sadiq Khan
Sadiq Khan Chief Commercial Officer @ Tevogen Bio
Chief Commercial Officer
2022-04-01

kirti-desai_image

Kirti Desai
Kirti Desai Chief Financial Officer @ Tevogen Bio
Chief Financial Officer
2021-01-01

stephen-r-chen_image

Stephen R. Chen
Stephen R. Chen CTO @ Tevogen Bio
CTO
2022-04-01

kevin-mcgrath_image

Kevin McGrath
Kevin McGrath COO @ Tevogen Bio
COO
2021-01-01

william-keane_image

William Keane
William Keane Vice President of Strategic Initiatives @ Tevogen Bio
Vice President of Strategic Initiatives
2024-05-16

ryan-saadi_image

Ryan Saadi
Ryan Saadi Founder, Chair and Chief Executive Officer @ Tevogen Bio
Founder, Chair and Chief Executive Officer
2020-05-01

tommy-joyce_image

Tommy Joyce
Tommy Joyce Head, Investor Relations and Government Affairs @ Tevogen Bio
Head, Investor Relations and Government Affairs
2021-01-01

mittul-mehta_image

Mittul Mehta
Mittul Mehta CIO & Head Tevogen AI @ Tevogen Bio
CIO & Head Tevogen AI
2023-10-01

Founder


ryan-saadi_image

Ryan Saadi

Stock Details


Company's stock symbol is NASDAQ:TVGN

Investors List

hmp-partners-d486_image

HMP Partners

HMP Partners investment in Series B - Tevogen Bio

hmp-partners-f259_image

HMP Partners

HMP Partners investment in Venture Round - Tevogen Bio

Official Site Inspections

http://www.tevogen.com Semrush global rank: 10.77 M Semrush visits lastest month: 202

  • Host name: 192.0.78.209
  • IP address: 192.0.78.209
  • Location: San Francisco United States
  • Latitude: 37.7506
  • Longitude: -122.4121
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94110

Loading ...

More informations about "Tevogen Bio"

Home - Tevogen.ai

Jan 23, 2025 Since entering our agreement with Microsoft, Tevogen.AI has been creating the base for its PredicTcell platform to develop multiple foundational models. This entailed expanded our dataset of viruses and diseases backed …See details»

Tevogen Bio - Crunchbase Company Profile & Funding

A clinical stage biotech company developing curative and preventative treatments to positively impact global public health. Tevogen is developing T cell …See details»

Tevogen Bio Inc. - Investor Relations

Apr 28, 2025 At Tevogen Bio Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are …See details»

Tevogen Bio - VentureRadar

" Tevogen’s unique T cell therapy approach is a major scientific breakthrough under development and investigation to treat COVID-19, Influenza, almost all Solid Tumors and common …See details»

Tevogen Bios Long-Term Vision Amidst Financial Struggles

Apr 15, 2025 In a climate where biotechnology firms are under increasing pressure to demonstrate financial viability, Dr. Ryan Saadi, the CEO and founder of Tevogen Bio Holdings …See details»

About - Tevogen

Sadiq Khan, MBA, joins Tevogen to lead its Global Commercial organization. He brings over 30 years of commercial leadership, operations, and alliance management experience. Most …See details»

Tevogen CEO Reaffirms the Company’s Commitment to Closing …

WARREN, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing …See details»

Tevogen Bio Prepares Organizational Readiness to Support …

Nov 26, 2024 “Tevogen’s C.O.R.E. values reflect leaderships commitment to embracing diverse perspectives, encouraging a readiness to learn, and creating solutions with a shared purpose,” …See details»

Tevogen charts new path of expansion and medical innovation at …

Apr 25, 2025 From Tevogen’s perspective, CIC offered not only the space, but also the state-of-the-art shared equipment and support structure they needed, exactly when they needed it. For …See details»

Tevogen Bio Holdings Inc. Secures $50 Million Agreement with

Apr 28, 2025 Potential Positives. Tevogen has secured an agreement with CD8 Technology Services LLC that provides up to $50 million, enhancing its dedicated R&D and manufacturing …See details»

Tevogen Bio Inc. - Tevogen Bio Prepares Organizational Readiness …

WARREN, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) - Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing …See details»

Tevogen Bio Prepares Organizational Readiness to Support

Nov 26, 2024 Tapan V Shah, Head of Investor Relations and Corporate Development, will take on added responsibility for US Government Affairs and Policy. William Keane, Vice President …See details»

Technology - Tevogen

Tevogen’s commercial scale ready manufacturing process yields a highly efficient ratio of doses per cell donor. ExacTcell focuses on the selection and expansion of naturally occurring, …See details»

Tevogen Bio Inc. - Tevogen Bio CEO Reflects on Public Support ...

WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) - Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing …See details»

Newsroom - Tevogen

6 days ago Tevogen Bio – May 2, 2025. CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment. …See details»

Investors - Tevogen

Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Tevogen’s …See details»

Tevogen Bio Prepares Organizational Readiness to Support …

Nov 26, 2024 Warren, N.J., Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically …See details»

Pipeline - Tevogen

Tevogen Bio is developing therapeutic products that not only treat cancer but also enable oncology patients to maintain uninterrupted therapy. Addition of non-oncology products to the …See details»

Tevogen Bio Inc. - Tevogen CEO Expresses Gratitude for …

WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) - Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ) is a clinical-stage specialty immunotherapy biotech …See details»

Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 …

Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts. Tevogen Bio Communications T: 1 877 TEVOGEN, Ext 701See details»

linkstock.net © 2022. All rights reserved